Epstein-Barr Virus (EBV) In Situ Hybridization, Technical Component Only
Use
This test is used for the detection of Epstein-Barr virus (EBV)-encoded RNA, which is helpful in the diagnosis of EBV-associated conditions such as infectious mononucleosis, nasopharyngeal carcinoma, Burkitt lymphoma, B-cell lymphomas in immunocompromised patients, and some cases of classical Hodgkin lymphoma.
Special Instructions
Not provided.
Limitations
The test does not include pathologist interpretation, only the technical performance of the stain. Proper interpretation should be performed by a qualified pathologist considering the patient's clinical history and other diagnostic tests. The test's performance characteristics were determined consistent with CLIA requirements but have not been FDA cleared or approved. The age of paraffin sections may affect results, and slide conditions can affect staining quality.
New York Approved
Methodology
Chromosomal / Cytogenetics (ISH)
Biomarkers
LOINC Codes
- Order only;no result
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Immunostain Technical Only Envelope
Storage Instructions
Minimize time slides are stored after being unpackaged. Limit exposure to high humidity and heat. Minimize exposure to plastics.
Causes for Rejection
Wet/frozen tissue, cytology smears, nonformalin fixed tissue, nonparaffin embedded tissue, noncharged slides, ProbeOn slides, Snowcoat slides